A. Portnoy

Challenges of antibacterial discovery revisited

David J Payne, Michael N Gwynn, D. Payne, 2010, Annals of the New York Academy of Sciences.

Evaluation Of Afuresertib, An Oral Pan-AKT Inhibitor, In Patients With Langerhans Cell Histiocytosis

R. Arceci, E. Jacobsen, C. Rodríguez-Galindo, 2013 .

Effects of Urotensin II Receptor Antagonist, GSK1440115, in Asthma

D. Behm, J. Throup, A. Portnoy, 2013, Front. Pharmacol..

A phase IIa study of afuresertib, an oral pan‐AKT inhibitor, in patients with Langerhans cell histiocytosis

R. Arceci, M. Cornfeld, E. Jacobsen, 2017, Pediatric Blood & Cancer.

No let up in the search for novel antibiotics

Z. Hong, D. Payne, A. Portnoy, 2009, Expert review of anti-infective therapy.

Estimating national-level measles case fatality ratios: an updated systematic review and modelling study

M. Jit, J. Mosser, A. Portnoy, 2022, medRxiv.

Inhibitory Antibiotic Concentrations the Mutant Prevention and Minimum Dynamic Models: the Predictive Power of In Vitro Bacterial Resistance Studies Using

M. Edelstein, V. Kozyreva, A. Portnoy, 2014 .